Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 3, 2023, 4:53 p.m.

/zigman2/quotes/200043077/composite

$

31.07

Change

-0.63 -1.99%

Volume

Volume 25,661

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Previous close

$ 32.67

$ 31.70

Change

-0.97 -2.97%

Day low

Day high

$31.52

$32.81

Open

52 week low

52 week high

$20.24

$39.43

Open

Robert Taylor Nelsen

Founder of 7 different companies, among them: Juno Therapeutics, Inc., Vir Biotechnology, Inc. and Sana Biotechnology, Inc. Robert Taylor Nelsen and is Chairman of Hua Medicine Ltd., Chairman of National Resilience, Inc., Chief Executive Officer & Director at Brii Biosciences, Inc. and Managing Director at ARCH Venture Partners LLC (which he founded in 2010), Managing Director at ARCH Venture Corp. and Managing Director at ARCH Venture Partners LP (which he founded in 1986) (both are subsidiaries of ARCH Venture Partners LLC). Mr. Nelsen is also Managing Director at ARCH Venture Corp. and on the board of 23 other companies.

Mr. Nelsen previously was Senior Manager at ARCH Development Partners LLC, Director at Accelerator Services Corp., Senior Manager at ARCH Development Corp., Independent Director at Juno Therapeutics, Inc. and Director at Revolution Healthcare Acquisition Corp.

Robert Taylor Nelsen received an undergraduate degree from the University of Puget Sound and an MBA from The University of Chicago.

Transactions

Date Shares Transaction Value
06/02/2021 2,074   Award at $0 per share. 0
06/01/2021 3,253   Derivative/Non-derivative trans. at $0 per share. 0
05/12/2021 2,537   0
03/22/2021 2,538   0
08/08/2019 2,030   0

Officers and Executives

Dr. Ryan J. Watts
President, Chief Executive Officer & Director
Dr. Alexander O. Schuth
Secretary, Chief Operating & Financial Officer
Dr. Joe Lewcock
Chief Scientific Officer
Dr. Carole Ho
Chief Medical Officer & Head-Development
Dr. Dana Andersen
CTO & Chief Manufacturing Officer
Ms. Katie Peng
Chief Commercial Officer
Mr. Steve E. Krognes
Director
Dr. Laura G. Hansen
Vice President-Investor Relations
Ms. Cindy Dunkle
Chief People Officer
Dr. Chris Walsh
Associate General Counsel
Ms. Erica Kratz
Vice President-Regulatory
Dr. Vicki L. Sato
Non-Executive Chairman
Ms. Nancy A. Thornberry
Independent Director
Mr. Erik C. Harris
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Douglas G. Cole
Independent Director
Mr. Jay T. Flatley
Independent Director
Mr. Robert Taylor Nelsen
Independent Director
Dr. David Paul Schenkein
Independent Director
Mr. Peter S. Klein
Independent Director
Ms. Jennifer E. Cook
Independent Director
Link to MarketWatch's Slice.